Jiajun Du
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 12
- Inflammatory Biomarkers in Disease Prognosis 11
- Lung Cancer Research Studies 10
- Health Informatics top 5%
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 7
-
- Lung Cancer Treatments and Mutations 29
- Lung Cancer Diagnosis and Treatment 23
- Ferroptosis and cancer prognosis 11
- Immunology top 10%
-
- Esophageal Cancer Research and Treatment 10
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Jiajun Du
91 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 133
- Oncology 934
- Health Informatics 36
- Cancer Research 333
- Pulmonary and Respiratory Medicine 547
- Immunology 340
Countries citing papers authored by Jiajun Du
This map shows the geographic impact of Jiajun Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiajun Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiajun Du more than expected).
Fields of papers citing papers by Jiajun Du
This network shows the impact of papers produced by Jiajun Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiajun Du. The network helps show where Jiajun Du may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiajun Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 43 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 12 | |
| 8 | 2020 | 14 | |
| 9 | 2020 | 12 | |
| 10 | 2018 | 23 | |
| 11 | 2015 | 7 | |
| 12 | 2015 | 43 | |
| 13 | 2015 | 39 | |
| 14 | 2014 | 270 | |
| 15 | 2014 | 132 | |
| 16 | 2014 | 11 | |
| 17 | 2014 | 6 | |
| 18 | 2013 | 40 | |
| 19 | 2012 | 44 | |
| 20 | 2012 | 25 |
About Jiajun Du
Jiajun Du is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Internal Medicine and Otorhinolaryngology, having authored 96 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Diagnosis and Treatment (23 papers), Cancer Immunotherapy and Biomarkers (12 papers), Ferroptosis and cancer prognosis (11 papers), Inflammatory Biomarkers in Disease Prognosis (11 papers), Esophageal Cancer Research and Treatment (10 papers), Lung Cancer Research Studies (10 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Oncology (934 citations), Health Informatics (36 citations), Cancer Research (333 citations), Pulmonary and Respiratory Medicine (547 citations) and Immunology (340 citations). Jiajun Du has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Hongchang Shen, Guanghui Wang, Qi Liu, Hongtao Lu, Pingping Hu, Frede Donskov, Zhaofei Pang, Qi Liu, Pingping Hu and Yang Ni. Their work appears in journals such as PLoS ONE, Medicine, Future Oncology, Scientific Reports and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.